CAS 261953-36-0

6-iodo-1H-indazole

Codes: AXIT-022

Application context (from source-drug indications)

Renal cell carcinomaAxitinibNeuroendocrine tumourAxitinibAdenoid cystic carcinomaAxitinibParagangliomaAxitinibPhaeochromocytomaAxitinibDuctal carcinomaAxitinib

Source drugs (routes using this intermediate)

Drug	Tier	Expiry
Axitinib	Tier B — Position early	-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

AxitinibProcess routesteps: 3total yield: 28 kg

2-vinylpyridine→2-mercapto-N-methylbenzamide→6-iodo-1H-indazole→2-((1H-indazol-6-yl)thio)-N-methylbenzamide→2-((3-iodo-1H-indazol-6-yl)thio)-N-methylbenzamide

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

Supplier	Product	Price band	MOQ	Lead time	Qualifications	Action
Unibest Nantong cGMP Site	6-Iodo-1H-indazole Pharmaceutical Intermediates	On request	On request	On request	—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.